The effect of nasal polyp epithelial cells on eosinophil activation

Laryngoscope

Volumn 113, Issue 8, 2003, Pages 1374-1377

  Shin, Seung Heon ^a   Lee, Sang Heon ^b   Jeong, Hyo Soon ^c   Kita, Hirohito ^d  

^a Catholic University of Daegu   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c Keimyung University School of Medicine   (South Korea)

^d MAYO CLINIC   (United States)

Author keywords

Cytokine; Eosinophil; Epithelial cell; Nasal polyp

Indexed keywords

EOTAXIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 8; NEUROTOXIN; RANTES; SUPEROXIDE;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EPITHELIUM CELL; HUMAN; HUMAN CELL; NOSE POLYP; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELLS, CULTURED; CHEMOKINES, CC; CULTURE MEDIA, CONDITIONED; EOSINOPHIL-DERIVED NEUROTOXIN; EOSINOPHILS; EPITHELIAL CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-8; NASAL POLYPS; RANTES; RIBONUCLEASES; SUPEROXIDES;

EID: 0041622799     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200308000-00020     Document Type: Article

References (19)

1. Darke-Lee AB, Pitcher WR. The clinical and laboratory correlates of nasal polyps in cystic fibrosis. Int J Pediatr Otolaryngol 1982;4:209-214.
2. Bernstein JM, Gorfien J, Noble B. Role of allergy in nasal polyposis: a review. Otolaryngol Head Neck Surg 1995;113:724-732.
3. Gleich GJ, Flavanhan NA, Fujisawa T, Wanhoutte PM. The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. J Allergy Clin Immunol 1988;81:776-781.
4. Venge P, Bystrom J. Molecules in focus eosinophil cationic protein (ECP). Int J Biochem Cell Biol 1998;30:433-437.
5. Harlin SL. Ansel DG, Lane SR, Myers J, Kephart GM, Gleich GJ. A clinical and pathologic study of chronic sinusitis: the role of the eosinophil. J Allergy Clin Immunol 1988;1:867-875.
6. Kahn DA, Cody II DT, George TJ, Gleich GJ, Leiferman KM. Allergic fungal sinusitis: an immunohistochemical analysis. J Allergy Clin Immunol 2000;106:1096-1101.
7. Kenney JS, Baker C, Welch MR, Altman LC. Synthesis of interleukin-1α, interleukin-6, and interleukin-8 by cultured human nasal epithelial cells. J Allergy Clin Immunol 1994;93:1060-1067.
8. Roca-Ferrer J, Mullol J, Lopez E, et al. Effect of topical anti-inflammatory drugs on epithelial cell-induced eosinophil survival and GM-CSF secretion. Eur Respir J 1997;10:1489-1495.
9. Hansel TT, De Vries IJ, Iff T, et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Method 1991;145:105-110.
10. Horie S, Kita H. CD 11b/CD 18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor. J Immunol 1994;162:5457-5467.
11. Kita H, Weiler DA, Abu-Ghazaleh R, Sanderson CJ, Gleich GJ. Release of granule proteins from eosinophils cultured with IL-5. J Immunol 1992;149:629-35.
12. Horie S, Gleich GJ, Kita H. Cytokines directly induce degranulation and superoxide production from human eosinophils. J Allergy Clin Immuno 1996;98:371-81.
13. Shute JK, Lindley I, Peichel P, Hogate ST, Church MK, Djukanovic R. Mucosal IgA is an important moderator of eosinophil response to tissue-derived chemoattractants. Int Arch Allergy Immunol 1995;107:340-341.
14. Mio T, Adachi Y, Romberger DJ, Illig MG, Robbins RA, Rennard SI. Modulation of IL-8 release from human bronchial epithelial cells by tumor necrosis factor-α, endotoxin and cigarette smoke. Am J Respir Crit Care Med 1994;149:A1070.
15. Alam R, Stafford S, Forsythe P, et al. RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 1993;150:3442-3447.
16. Nagai K, Larkin S, Hartnell A, et al. Human eotaxin induces eosinophil extravasation through rat mesenteric venules: role of 4 integrins and vascular cell adhesion molecule-1. Immunology 1999;96:176-183.
17. Fujisawa T, Kato Y, Nagase H, et al. Chemokines induce eosinophil degranulation through CCR-3. J Allergy Clin Immunol 2000;106:507-513.
18. Sedgwick JB, Stuart SF, Calhoun WJ, Busse WW. Effect of interleukin-5 and granulocyte-macrophage colony stimulating factor on in vitro eosinophil function: comparison with airway eosinophils. J Allergy Clin Immunol 1995;96:375-385.
19. Lopez AF, Eglinton JM, Gillis D, Park LS, Clark S, Vadas MA. Reciprocal inhibition of binding between interleukin 3 and granulocyte-macrophage colony-stimulating factor to human eosinophils. Proc Natl Acad Sci U S A 1989;86:7022.